Skip to main content
Erschienen in: Archives of Virology 4/2017

27.12.2016 | Annotated Sequence Record

Characterization and genome analysis of novel bacteriophages infecting the opportunistic human pathogens Klebsiella oxytoca and K. pneumoniae

verfasst von: Eun-Ah Park, You-Tae Kim, Jae-Hyun Cho, Sangryeol Ryu, Ju-Hoon Lee

Erschienen in: Archives of Virology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Klebsiella is a genus of well-known opportunistic human pathogens that are associated with diabetes mellitus and chronic pulmonary obstruction; however, this pathogen is often resistant to multiple drugs. To control this pathogen, two Klebsiella-infecting phages, K. oxytoca phage PKO111 and K. pneumoniae phage PKP126, were isolated from a sewage sample. Analysis of their host range revealed that they infect K. pneumoniae and K. oxytoca, suggesting host specificity for members of the genus Klebsiella. Stability tests confirmed that the phages are stable under various temperature (4 to 60 °C) and pH (3 to 11) conditions. A challenge assay showed that PKO111 and PKP126 inhibit growth of their host strains by 2 log and 4 log, respectively. Complete genome sequencing of the phages revealed that their genome sizes are quite different (168,758 bp for PKO111 and 50,934 bp for PKP126). Their genome annotation results showed that they have no human virulence-related genes, an important safety consideration. In addition, no lysogen-formation gene cluster was detected in either phage genome, suggesting that they are both virulent phages in their bacterial hosts. Based on these results, PKO111 and PKP126 may be good candidates for development of biocontrol agents against members of the genus Klebsiella for therapeutic purposes. A comparative analysis of tail-associated gene clusters of PKO111 and PKP126 revealed relatively low homology, suggesting that they might differ in the way they recognize and infect their specific hosts.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Abbasifar R, Kropinski AM, Sabour PM, Ackermann HW, Lingohr EJ, Griffiths MW (2012) Complete genome sequence of Cronobacter sakazakii bacteriophage vB_CsaM_GAP161. J Virol 86:13806–13807CrossRefPubMedPubMedCentral Abbasifar R, Kropinski AM, Sabour PM, Ackermann HW, Lingohr EJ, Griffiths MW (2012) Complete genome sequence of Cronobacter sakazakii bacteriophage vB_CsaM_GAP161. J Virol 86:13806–13807CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Adams MH (1959) Enumeration of bacteriophage particles. Bacteriophages. Interscience Publishers, New York, pp 27–30 Adams MH (1959) Enumeration of bacteriophage particles. Bacteriophages. Interscience Publishers, New York, pp 27–30
3.
Zurück zum Zitat Altermann E, Klaenhammer TR (2003) GAMOLA: a new local solution for sequence annotation and analyzing draft and finished prokaryotic genomes. OMICS 7:161–169CrossRefPubMed Altermann E, Klaenhammer TR (2003) GAMOLA: a new local solution for sequence annotation and analyzing draft and finished prokaryotic genomes. OMICS 7:161–169CrossRefPubMed
4.
Zurück zum Zitat Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402CrossRefPubMedPubMedCentral Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Besemer J, Lomsadze A, Borodovsky M (2001) GeneMarkS: a self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions. Nucleic Acids Res 29:2607–2618CrossRefPubMedPubMedCentral Besemer J, Lomsadze A, Borodovsky M (2001) GeneMarkS: a self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions. Nucleic Acids Res 29:2607–2618CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Bouza E, Cercenado E (2002) Klebsiella and Enterobacter: antibiotic resistance and treatment implications. Semin Resp Infect 17:215–230CrossRef Bouza E, Cercenado E (2002) Klebsiella and Enterobacter: antibiotic resistance and treatment implications. Semin Resp Infect 17:215–230CrossRef
7.
Zurück zum Zitat Cao F, Wang X, Wang L, Li Z, Che J, Wang L, Li X, Cao Z, Zhang J, Jin L (2015) Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice. Biomed Res Int 2015:752930PubMedPubMedCentral Cao F, Wang X, Wang L, Li Z, Che J, Wang L, Li X, Cao Z, Zhang J, Jin L (2015) Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice. Biomed Res Int 2015:752930PubMedPubMedCentral
8.
Zurück zum Zitat Carver TJ, Rutherford KM, Berriman M, Rajandream M-A, Barrell BG, Parkhill J (2005) ACT: the Artemis comparison tool. Bioinformatics 21:3422–3423CrossRefPubMed Carver TJ, Rutherford KM, Berriman M, Rajandream M-A, Barrell BG, Parkhill J (2005) ACT: the Artemis comparison tool. Bioinformatics 21:3422–3423CrossRefPubMed
9.
Zurück zum Zitat Demirdag K, Hosoglu S (2010) Epidemiology and risk factors for ESBL-producing Klebsiella pneumoniae: a case control study. J Infect Dev Ctries 4:717–722PubMed Demirdag K, Hosoglu S (2010) Epidemiology and risk factors for ESBL-producing Klebsiella pneumoniae: a case control study. J Infect Dev Ctries 4:717–722PubMed
10.
Zurück zum Zitat Deresinski S (2009) Bacteriophage therapy: exploiting smaller fleas. Clin Infect Dis 48:1096–1101CrossRefPubMed Deresinski S (2009) Bacteriophage therapy: exploiting smaller fleas. Clin Infect Dis 48:1096–1101CrossRefPubMed
11.
Zurück zum Zitat Duckworth DH, Gulig PA (2002) Bacteriophages: potential treatment for bacterial infections. BioDrugs 16:57–62CrossRefPubMed Duckworth DH, Gulig PA (2002) Bacteriophages: potential treatment for bacterial infections. BioDrugs 16:57–62CrossRefPubMed
12.
Zurück zum Zitat Failla ML, Benedict C, Weinberg E (1975) Bacterial and fungal growth in total parenteral nutrition solutions. Antonie Van Leeuwenhoek 41:319–328CrossRefPubMed Failla ML, Benedict C, Weinberg E (1975) Bacterial and fungal growth in total parenteral nutrition solutions. Antonie Van Leeuwenhoek 41:319–328CrossRefPubMed
13.
14.
Zurück zum Zitat Hayashi K, Morooka N, Yamamoto Y, Fujita K, Isono K, Choi S, Ohtsubo E, Baba T, Wanner BL, Mori H (2006) Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol Syst Biol 2(2006):0007PubMed Hayashi K, Morooka N, Yamamoto Y, Fujita K, Isono K, Choi S, Ohtsubo E, Baba T, Wanner BL, Mori H (2006) Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol Syst Biol 2(2006):0007PubMed
16.
Zurück zum Zitat Hirsch EB, Tam VH (2010) Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrobe Chemother 65:1119–1125CrossRef Hirsch EB, Tam VH (2010) Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrobe Chemother 65:1119–1125CrossRef
17.
Zurück zum Zitat Kumari S, Harjai K, Chhirbber S (2010) Topical treatment of Klebsiella pneumoniae B5055 induced burn wound infection in mice using natural products. J Infect Dev Ctries 4:367–377CrossRefPubMed Kumari S, Harjai K, Chhirbber S (2010) Topical treatment of Klebsiella pneumoniae B5055 induced burn wound infection in mice using natural products. J Infect Dev Ctries 4:367–377CrossRefPubMed
18.
Zurück zum Zitat Lang LH (2006) FDA approves use of bacteriophages to be added to meat and poultry product. Gastroenterology 131:1370PubMed Lang LH (2006) FDA approves use of bacteriophages to be added to meat and poultry product. Gastroenterology 131:1370PubMed
19.
Zurück zum Zitat Maal KB, Delfan AS, Salmanizadeh S (2014) Isolation and identification of Klebsiella pneumonia and Klebsiella oxytoca bacteriophages and their application in wastewater treatment and coliforrn’s phage therapy. Res J Environ Sci 8:123–138CrossRef Maal KB, Delfan AS, Salmanizadeh S (2014) Isolation and identification of Klebsiella pneumonia and Klebsiella oxytoca bacteriophages and their application in wastewater treatment and coliforrn’s phage therapy. Res J Environ Sci 8:123–138CrossRef
20.
Zurück zum Zitat Maki DG (1976) Growth properties of microorganisms in infusion fluid and methods of detection. In: Phillips I, Meers PD, D’Arcy PF (eds) Microbiological hazards of infusion therapy. Microbiological hazards of infusion therapy. MTP Press, Lancaster, pp 13–47CrossRef Maki DG (1976) Growth properties of microorganisms in infusion fluid and methods of detection. In: Phillips I, Meers PD, D’Arcy PF (eds) Microbiological hazards of infusion therapy. Microbiological hazards of infusion therapy. MTP Press, Lancaster, pp 13–47CrossRef
21.
Zurück zum Zitat McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F (2001) Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852–856CrossRefPubMed McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F (2001) Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852–856CrossRefPubMed
22.
23.
Zurück zum Zitat Park K-H, Kurokawa K, Zheng L, Jung D-J, Tateishi K, Jin J-O, Ha N-C, Kang HJ, Matsushita M, Kwak J-Y (2010) Human serum mannose-binding lectin senses wall teichoic acid Glycopolymer of Staphylococcus aureus, which is restricted in infancy. J Biol Chem 285:27167–27175CrossRefPubMedPubMedCentral Park K-H, Kurokawa K, Zheng L, Jung D-J, Tateishi K, Jin J-O, Ha N-C, Kang HJ, Matsushita M, Kwak J-Y (2010) Human serum mannose-binding lectin senses wall teichoic acid Glycopolymer of Staphylococcus aureus, which is restricted in infancy. J Biol Chem 285:27167–27175CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Park M, Lee J-H, Shin H, Kim M, Choi J, Kang D-H, Heu S, Ryu S (2012) Characterization and comparative genomic analysis of a novel bacteriophage, SFP10, simultaneously inhibiting both Salmonella enterica and Escherichia coli O157:H7. Appl Environ Microbiol 78:58–69CrossRefPubMedPubMedCentral Park M, Lee J-H, Shin H, Kim M, Choi J, Kang D-H, Heu S, Ryu S (2012) Characterization and comparative genomic analysis of a novel bacteriophage, SFP10, simultaneously inhibiting both Salmonella enterica and Escherichia coli O157:H7. Appl Environ Microbiol 78:58–69CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11:589–603PubMedPubMedCentral Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11:589–603PubMedPubMedCentral
26.
Zurück zum Zitat Pomakova D, Hsiao C, Beanan J, Olson R, MacDonald U, Keynan Y, Russo T (2012) Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant. Eur J Clin Microbiol Infect Dis 31:981–989CrossRefPubMed Pomakova D, Hsiao C, Beanan J, Olson R, MacDonald U, Keynan Y, Russo T (2012) Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant. Eur J Clin Microbiol Infect Dis 31:981–989CrossRefPubMed
27.
Zurück zum Zitat Quevillon E, Silventoinen V, Pillai S, Harte N, Mulder N, Apweiler R, Lopez R (2005) InterProScan: protein domains identifier. Nucleic Acids Res 33:W116–W120CrossRefPubMedPubMedCentral Quevillon E, Silventoinen V, Pillai S, Harte N, Mulder N, Apweiler R, Lopez R (2005) InterProScan: protein domains identifier. Nucleic Acids Res 33:W116–W120CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Ribot EM, Wierzba RK, Angulo FJ, Barrett TJ (2002) Salmonella enterica serotype Typhimurium DT104 isolated from humans, United States, 1985, 1990, and 1995. Emerg Infect Dis 8:387–391CrossRefPubMedPubMedCentral Ribot EM, Wierzba RK, Angulo FJ, Barrett TJ (2002) Salmonella enterica serotype Typhimurium DT104 isolated from humans, United States, 1985, 1990, and 1995. Emerg Infect Dis 8:387–391CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream M-A, Barrell B (2000) Artemis: sequence visualization and annotation. Bioinformatics 16:944–945CrossRefPubMed Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream M-A, Barrell B (2000) Artemis: sequence visualization and annotation. Bioinformatics 16:944–945CrossRefPubMed
30.
Zurück zum Zitat Shen Y-J, Jiang H, Jin J-P, Zhang Z-B, Xi B, He Y-Y, Wang G, Wang C, Qian L, Li X (2004) Development of genome-wide DNA polymorphism database for map-based cloning of rice genes. Plant Physiol 135:1198–1205CrossRefPubMedPubMedCentral Shen Y-J, Jiang H, Jin J-P, Zhang Z-B, Xi B, He Y-Y, Wang G, Wang C, Qian L, Li X (2004) Development of genome-wide DNA polymorphism database for map-based cloning of rice genes. Plant Physiol 135:1198–1205CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Shoma S, Kamruzzaman M, Ginn AN, Iredell JR, Partridge SR (2014) Characterization of multidrug-resistant Klebsiella pneumoniae from Australia carrying blaNDM-1. Diagn Microbiol Infect Dis 78:93–97CrossRefPubMed Shoma S, Kamruzzaman M, Ginn AN, Iredell JR, Partridge SR (2014) Characterization of multidrug-resistant Klebsiella pneumoniae from Australia carrying blaNDM-1. Diagn Microbiol Infect Dis 78:93–97CrossRefPubMed
32.
Zurück zum Zitat Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, Thompson JD, Higgins DG (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539CrossRefPubMedPubMedCentral Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, Thompson JD, Higgins DG (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Struve C, Krogfelt KA (2004) Pathogenic potential of environmental Klebsiella pneumoniae isolates. Environ Microbiol 6:584–590CrossRefPubMed Struve C, Krogfelt KA (2004) Pathogenic potential of environmental Klebsiella pneumoniae isolates. Environ Microbiol 6:584–590CrossRefPubMed
34.
Zurück zum Zitat Tamura K, Stecher G, Peterson D, Filipski A, Kumar S (2013) MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30:2725–2729CrossRefPubMedPubMedCentral Tamura K, Stecher G, Peterson D, Filipski A, Kumar S (2013) MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30:2725–2729CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Tatusova TA, Madden TL (1999) BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett 174:247–250CrossRefPubMed Tatusova TA, Madden TL (1999) BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett 174:247–250CrossRefPubMed
36.
Zurück zum Zitat Unerwood AP, Mulder A, Gharbia S, Green J (2005) Virulence Searcher: a tool for searching raw genome sequences from bacterial genomes for putative virulence factors. Clin Microbiol Infect 11:770–772CrossRef Unerwood AP, Mulder A, Gharbia S, Green J (2005) Virulence Searcher: a tool for searching raw genome sequences from bacterial genomes for putative virulence factors. Clin Microbiol Infect 11:770–772CrossRef
37.
Zurück zum Zitat Verma V, Harjai K, Chhibber S (2009) Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent. Curr Microbiol 59:274–281CrossRefPubMed Verma V, Harjai K, Chhibber S (2009) Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent. Curr Microbiol 59:274–281CrossRefPubMed
38.
Zurück zum Zitat Wilcox S, Toder R, Foster J (1996) Rapid isolation of recombinant lambda phage DNA for use in fluorescence in situ hybridization. Chromosome Res 4:397–404CrossRefPubMed Wilcox S, Toder R, Foster J (1996) Rapid isolation of recombinant lambda phage DNA for use in fluorescence in situ hybridization. Chromosome Res 4:397–404CrossRefPubMed
39.
Zurück zum Zitat Wu L-T, Chang S-Y, Yen M-R, Yang T-C, Tseng Y-H (2007) Characterization of extended-host-range pseudo-T-even bacteriophage Kpp95 isolated on Klebsiella pneumoniae. Appl Environ Microbiol 73:2532–2540CrossRefPubMedPubMedCentral Wu L-T, Chang S-Y, Yen M-R, Yang T-C, Tseng Y-H (2007) Characterization of extended-host-range pseudo-T-even bacteriophage Kpp95 isolated on Klebsiella pneumoniae. Appl Environ Microbiol 73:2532–2540CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Zhu J, Jiang R, Kong H, Zhang R, Lü H, Sun C, Huang Z (2013) Emergence of novel variants of gyrA, parC, qnrS genes in multi-drug resistant Klebsiella caused pneumonia. Zhonghua Liu Xing Bing Xue Za Zhi 34:61–66PubMed Zhu J, Jiang R, Kong H, Zhang R, Lü H, Sun C, Huang Z (2013) Emergence of novel variants of gyrA, parC, qnrS genes in multi-drug resistant Klebsiella caused pneumonia. Zhonghua Liu Xing Bing Xue Za Zhi 34:61–66PubMed
Metadaten
Titel
Characterization and genome analysis of novel bacteriophages infecting the opportunistic human pathogens Klebsiella oxytoca and K. pneumoniae
verfasst von
Eun-Ah Park
You-Tae Kim
Jae-Hyun Cho
Sangryeol Ryu
Ju-Hoon Lee
Publikationsdatum
27.12.2016
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 4/2017
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-016-3202-3

Weitere Artikel der Ausgabe 4/2017

Archives of Virology 4/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.